Despite the successful proof of principle for the applicability of genome-wide association studies in the genetics of complex diseases, the contribution of certain IL23R variants to CD or UC is not sufficiently strong to explain the genetic background of IBD on its own. This evidence concerns the gene IL23R and inflammatory bowel disease.